Thomas J Hoerger
Overview
Explore the profile of Thomas J Hoerger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
2084
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khavjou O, Sun M, DAngelo S, Neuwahl S, Hoerger T, Cho P, et al.
Diabetes Care
. 2024 Aug;
PMID: 39121032
Objective: To update state-specific estimates of diabetes-attributable costs in the U.S. and assess changes in spending from 2013 to 2021. Research Design And Methods: We used an attributable fraction approach...
2.
Hoerger T, Hilscher R, Neuwahl S, Kaufmann M, Shao H, Laxy M, et al.
Value Health
. 2023 May;
26(9):1372-1380.
PMID: 37236396
Objectives: This study aimed to develop a microsimulation model to estimate the health effects, costs, and cost-effectiveness of public health and clinical interventions for preventing/managing type 2 diabetes. Methods: We...
3.
Neuwahl S, Sharma A, Zhang P, Hoerger T
Prev Chronic Dis
. 2022 Dec;
19:E89.
PMID: 36580414
Purpose And Objectives: The objective of our study was to model the costs and benefits of 2 screening criteria for people with gestational diabetes. Because people with a history of...
4.
Neuwahl S, Zhang P, Chen H, Shao H, Laxy M, Anderson A, et al.
Diabetes Care
. 2020 Dec;
44(2):381-389.
PMID: 33277301
Objective: To estimate the health utility impact of diabetes-related complications in a large, longitudinal U.S. sample of people with type 2 diabetes. Research Design And Methods: We combined Health Utilities...
5.
Barbosa C, Fraser H, Hoerger T, Leib A, Havens J, Young A, et al.
Addiction
. 2019 Jul;
114(12):2267-2278.
PMID: 31307116
Aims: To examine the cost-effectiveness of hepatitis C virus (HCV) treatment of people who inject drugs (PWID), combined with medication-assisted treatment (MAT) and syringe-service programs (SSP), to tackle the increasing...
6.
Allaire B, Ekweme D, Hoerger T, DeGroff A, Rim S, Subramanian S, et al.
Cancer Causes Control
. 2019 Jul;
30(9):923-929.
PMID: 31297693
Objectives: Patient navigation (PN) services have been shown to improve cancer screening in disparate populations. This study estimates the cost-effectiveness of implementing PN services within the National Breast and Cervical...
7.
Fraser H, Vellozzi C, Hoerger T, Evans J, Kral A, Havens J, et al.
Am J Epidemiol
. 2019 Jun;
188(8):1539-1551.
PMID: 31150044
In the United States, hepatitis C virus (HCV) transmission is rising among people who inject drugs (PWID). Many regions have insufficient prevention intervention coverage. Using modeling, we investigated the impact...
8.
Rim S, Allaire B, Ekwueme D, Miller J, Subramanian S, Hall I, et al.
Cancer Causes Control
. 2019 May;
30(8):819-826.
PMID: 31098856
Purpose: To estimate the cost-effectiveness of breast cancer screening in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Methods: Using a modified CISNET breast cancer simulation model, we...
9.
Hoerger T
Curr Diab Rep
. 2019 May;
19(6):29.
PMID: 31037354
Purpose Of Review: The purpose of this review is to provide current synthesis of the evidence on the cost-effectiveness of bariatric surgery for persons with diabetes. Recent Findings: Virtually, every...
10.
Teixeira-Poit S, Treiman K, Li L, Hoerger T, Carmody D, Tardif-Douglin M
Am J Prev Med
. 2019 Mar;
56(4):563-570.
PMID: 30898222
Introduction: This study evaluates the effect of program and incentive characteristics on satisfaction with incentives and perceived impact of incentives on behavior change among Medicaid beneficiaries who participated in the...